COVID-19 and Indian pharma industry

Authors : G Vidyasagar

DOI : 10.18231/j.ijpp.2021.017

Volume : 8

Issue : 2

Year : 2021

Page No : 100-101


Citation Data


Related Articles

A prospective study of displaced supracondylar fractures of the humerus in children treated with open reduction and internal fixation with k-wires

K. Raja Ratnam, Jhatoth Dhoom Singh

Bacteriological profile and antibiotic susceptibility patterns of wound infections in a tertiary care hospital in South India

Roopashree S, A G Prathab, Sandeep T

Comparison of sub trochanteric femur fracture treatment with intra medullary proximal femur nail versus proximal femur nail with trochanteric support plate

Ajay Singh Thakur, Satwik Thareja, Sachin Patel, R N Sonkar*

Establishment of nuclear grade evaluation method for endometrial endometrioid carcinoma, and the significance of separately evaluating nuclear atypia of the glandular and solid structure parts

Haruhiko Yoshioka, Miho Iwaya, Kayo Horie, Yoshihito Yokoyama, Jun Watanabe

Green hospital - A necessity and not option

Shipra Kumari, Rajeev Kumar

Propensity of use of neuromuscular blocking agents among Indian anaesthesiologists: A questionnaire-based survey

Anil Kumar Jain, Shubha Hodarkar*

Pre-analytical errors in clinical biochemistry-a comparative study

Iram Hamid, Vinitha Ramnath Pai, Raghavendra .U, M.H. Sheriff

A new challenge for ‘Dental Professionals’ during this pandemic situation of COVID-19

Pragati S Dubey, Neelam Mittal, Prabhat Chandra

Role of circulating C-peptide in the Indian population with Type 2 diabetics with nephropathy: A triangular relationship between C-peptide, HbA1C and microalbuminuria

Balaji Vijayam*, Taarika Balaji, Madhuri S Balaji, Seshiah Veerasamy, Vinothkumar Ganesan*